Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1194 clinical trials
featured
Restless Legs Syndrome patients with iron-deficiency anemia Clinical Research Study

Do you have Restless Legs Syndrome with iron-deficiency anemia?  

iron
  • 169 views
  • 23 Nov, 2020
  • 1 location
featured
Alpha-1 Study: A research study for individuals with Alpha-1 Antitrypsin Deficiency

The Alpha-1 Study is a clinical research study currently enrolling individuals 18 to 78 (inclusive) with Alpha-1 Antitrypsin Deficiency.   The purpose of this study is to evaluate

alpha 1-antitrypsin
deficiency
alpha1-proteinase inhibitor (human)
  • 145 views
  • 23 Nov, 2020
  • 7 locations
featured
A Washington University research study is currently enrolling participants with primary Immune deficiency (PID). IRB ID #: 201910008

The purpose of this research study is to investigate different ways to dose with CUTAQUIG ® in patients suffering from primary Immune deficiency (PID).

immunodeficiency
immune deficiency
immune disorders
primary immunodeficiency
immune disorder
  • 0 views
  • 25 Jan, 2021
  • 1 location
featured
Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease

>Eligibility: Adults ages 18-80 of African descent. They may have sickle cell disease or not. They must not have had a transfusion recently or have a known deficiency of pyruvate kinase

red blood cell disorder
sickle cell anemia
sickle cell disease
  • 48 views
  • 22 Dec, 2020
  • 1 location
featured
A Phase IV, Multicenter, Open-Label Study of the Immunogenicity of Nutropin AQ® V1.1 [Somatropin (rDNA Origin) Injection] Administered Daily to Naive Growth Hormone-Deficient Children

A Phase IV, Multicenter, Open-Label Study of the Immunogenicity of Nutropin AQ® V1.1 [Somatropin (rDNA Origin) Injection] Administered Daily to Naive Growth Hormone-Deficient Children

  • 184 views
  • 25 Mar, 2021
  • 1 location
featured
Role of Genetic Factors in the Pathogenesis of Lung Disease

This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examining the genes in lung cells of patients with lung disease. The study will focus on defining the distribution of abnormal genes responsible for processes …

diabetes
bronchoscopy
pulmonary fibrosis
pulmonary disease
  • 120 views
  • 23 Nov, 2020
  • 1 location
featured
A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

  • 74 views
  • 25 Mar, 2021
  • 1 location
featured
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects

Background: People are living longer and are more likely to survive a heart attack if they have one. Longer life expectancy is good but it also means more people get chronic heart failure over time. This is a condition in which the heart doesn't pump blood as well as it …

systolic heart failure
heart failure
cardiopulmonary exercise testing
radionuclide ventriculography
chronic heart failure
  • 77 views
  • 09 Apr, 2019
  • 1 location
featured
Do You Have Osteoporosis?

Do You Have Osteoporosis?

  • 1122 views
  • 25 Mar, 2021
  • 1 location
featured
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

  • 106 views
  • 08 Dec, 2020
  • 1 location